Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionextracellular matrix structural constituent

THSD4 RELN COL6A5 COL24A1 ANOS1 PXDN SCARA3 LAMA4 MUC3A MUC4

5.62e-0518822510GO:0005201
GeneOntologyCellularComponentCOPI-coated Golgi to ER transport vesicle

GNAS CCDC88A

1.16e-0422262GO:0030142
GeneOntologyCellularComponentextracellular matrix

THSD4 RELN IL16 LGALS9B COL6A5 COL24A1 ANOS1 PXDN ANGPT4 NAV2 ADAMTS18 SCARA3 LAMA4 LINGO2 LGALS9 ENTPD2 MUC4 SERPINA5

2.95e-0465622618GO:0031012
GeneOntologyCellularComponentexternal encapsulating structure

THSD4 RELN IL16 LGALS9B COL6A5 COL24A1 ANOS1 PXDN ANGPT4 NAV2 ADAMTS18 SCARA3 LAMA4 LINGO2 LGALS9 ENTPD2 MUC4 SERPINA5

3.06e-0465822618GO:0030312
HumanPhenoHyperactive renin-angiotensin system

CLCNKA CLCNKB NR3C2 SLC26A3 SLC12A1

3.50e-088765HP:0000841
HumanPhenoHypochloremia

CLCNKA CLCNKB SLC26A3 SLC12A1

1.55e-067764HP:0003113
HumanPhenoIncreased circulating aldosterone concentration

CLCNKA CLCNKB NR3C2 GNAS SLC26A3 SLC12A1

6.02e-0632766HP:0000859
HumanPhenoIncreased circulating renin concentration

CLCNKA CLCNKB NR3C2 SLC26A3 SLC12A1

6.39e-0619765HP:0000848
HumanPhenoAbnormal circulating renin concentration

CLCNKA CLCNKB NR3C2 GNAS SLC26A3 SLC12A1

7.27e-0633766HP:0040084
HumanPhenoAbnormal urine chloride concentration

CLCNKA CLCNKB SLC12A1

3.12e-055763HP:0012600
HumanPhenoHyperchloriduria

CLCNKA CLCNKB SLC12A1

3.12e-055763HP:0002914
HumanPhenoAbnormality of aldosterone production

CLCNKA CLCNKB NR3C2 GNAS SLC26A3 SLC12A1

4.07e-0544766HP:0002855
HumanPhenoAbnormality of adrenal physiology

GATB GK CLCNKA CLCNKB NR3C2 GNAS HERC2 SLC26A3 SLC12A1 ROBO1

6.18e-051497610HP:0011733
HumanPhenoAbnormal circulating prostaglandin circulation

CLCNKA CLCNKB SLC12A1

6.18e-056763HP:0011023
HumanPhenoHyperprostaglandinuria

CLCNKA CLCNKB SLC12A1

6.18e-056763HP:0003527
HumanPhenoAbnormal circulating aldosterone concentration

CLCNKA CLCNKB NR3C2 GNAS SLC26A3 SLC12A1

9.55e-0551766HP:0040085
HumanPhenoMetabolic alkalosis

CLCNKA CLCNKB SLC26A3 SLC12A1

1.20e-0418764HP:0200114
HumanPhenoAdrenocortical abnormality

GK CLCNKA CLCNKB NR3C2 GNAS SLC26A3 SLC12A1

1.30e-0477767HP:0000849
HumanPhenoAbnormality of renin-angiotensin system

CLCNKA CLCNKB NR3C2 GNAS SLC26A3 SLC12A1

1.47e-0455766HP:0000847
HumanPhenoAdrenal overactivity

CLCNKA CLCNKB NR3C2 GNAS SLC26A3 SLC12A1

1.47e-0455766HP:0002717
HumanPhenoAbnormal circulating unsaturated fatty acid concentration

CLCNKA CLCNKB SLC12A1

1.69e-048763HP:0011022
HumanPhenoAbnormal circulating eicosanoid concentration

CLCNKA CLCNKB SLC12A1

1.69e-048763HP:0030361
HumanPhenoHyperostosis frontalis interna

ALMS1 GNAS

2.20e-042762HP:0004438
HumanPhenoHypokalemic metabolic alkalosis

CLCNKA CLCNKB SLC12A1

2.51e-049763HP:0001960
HumanPhenoIncreased urinary potassium

CLCNKA CLCNKB SLC12A1

2.51e-049763HP:0003081
DomainConA-like_dom

TRIML1 LGALS9B ADGRG4 COL24A1 HERC1 FAT3 RNF135 TSPEAR LAMA4 MAMDC4 LGALS9 ADGRD2 PROS1

2.67e-0621922513IPR013320
DomainWD40_repeat_dom

ARHGEF17 SHKBP1 PIK3R4 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 UBR4 NUP43 AMBRA1 SEC31B UTP18 DNAI4

3.37e-0629722515IPR017986
DomainWD40_repeat

SHKBP1 PIK3R4 HERC2 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4

5.79e-0627222514IPR001680
DomainWD_REPEATS_1

SHKBP1 PIK3R4 HERC2 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4

7.43e-0627822514PS00678
DomainWD_REPEATS_2

SHKBP1 PIK3R4 HERC2 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4

7.74e-0627922514PS50082
DomainWD_REPEATS_REGION

SHKBP1 PIK3R4 HERC2 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4

7.74e-0627922514PS50294
DomainWD40

SHKBP1 PIK3R4 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4

1.64e-0525922513PF00400
DomainWD40

SHKBP1 PIK3R4 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4

2.35e-0526822513SM00320
Domain-

ARHGEF17 SHKBP1 PIK3R4 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4

5.50e-05333225142.130.10.10
DomainWD40/YVTN_repeat-like_dom

ARHGEF17 SHKBP1 PIK3R4 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4

5.86e-0533522514IPR015943
DomainCl_channel-K

CLCNKA CLCNKB

1.44e-0422252IPR002250
Domain-

LGALS9B ADGRG4 COL24A1 FAT3 LAMA4 LGALS9 PROS1

1.51e-049522572.60.120.200
DomainPFKB_KINASES_2

RBKS KHK

4.30e-0432252PS00584
DomainCarboh/pur_kinase_PfkB_CS

RBKS KHK

4.30e-0432252IPR002173
DomainALMS_motif

ALMS1 CEP295

4.30e-0432252IPR029299
DomainALMS_motif

ALMS1 CEP295

4.30e-0432252PF15309
PathwayREACTOME_DECTIN_2_FAMILY

MUC21 CLEC10A MUC16 MUC3A MUC4

1.52e-05261765M27483
PathwayREACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC

MUC21 MUC16 MUC3A MUC4

3.80e-05161764M27410
PathwayREACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS

MUC21 MUC16 MUC3A MUC4

4.92e-05171764M27412
PathwayREACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS

SLC5A12 SLC26A3 SLC26A7

1.52e-0491763M27344
PathwayREACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS

SLC5A12 SLC26A3 SLC26A7

1.52e-0491763MM15084
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC21 MUC16 MUC3A MUC4

1.73e-04231764M556
PathwayREACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS

THSD4 MUC21 ADAMTS18 MUC16 MUC3A MUC4

2.01e-04681766M27303
PathwayREACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING

CACNA1E CACNB1 CACNB2

2.93e-04111763MM14498
PathwayREACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING

CACNA1E CACNB1 CACNB2

2.93e-04111763M26913
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

KDM3B TAB2 ARHGEF17 SHKBP1 PIK3R4 KCNQ5 ALMS1 STARD9 SVIL NAV2 KMT2A COBL NR3C2 GNAS KDM5A RAB11FIP1 CDC14A FAM83B GRIP1 VPS13D CCDC88A SIPA1L1 AKAP13 SH3RF3 PLK4 SAMD4A EXOC4

2.21e-118612282736931259
Pubmed

Human transcription factor protein interaction networks.

ATP5PO GATAD2A USP11 RC3H1 FLG2 INO80D ALMS1 SVIL KMT2A ZNF770 MLLT6 HERC2 HERC1 TAF1L HOMEZ NPAT CNOT11 NUP107 KDM5A RBM33 RBBP5 UBR4 PHF6 POU2F1 ZMIZ1 EXOC4

2.85e-0614292282635140242
Pubmed

Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.

KIF18A CTU2 IL16 SAV1 TAB2 COL24A1 SVIL MLLT6 TAF1L RUSF1 RAD17 CNOT11 UBR4 ADNP2 ROBO2 AKAP13 SAMD4A

3.54e-066892281736543142
Pubmed

Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.

KCNQ5 ALMS1 STARD9 DNAJB2 CACNA1E UBR4 DNAH2 CEP295 MAPK8IP2 ZNF292

3.60e-062332281037704626
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

CABLES1 COBL CKAP4 CACNB2 RAB11FIP1 FAM83B JPH1 GRIP1 CCDC88A KIRREL1 ROBO1 ROBO2 EXOC4

4.86e-064212281336976175
Pubmed

Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance.

LGALS9B CLEC7A LGALS9

5.48e-066228328394331
Pubmed

The role of Robo3 in the development of cortical interneurons.

RELN ROBO1 ROBO2

5.48e-066228319366869
Pubmed

A High-Density Human Mitochondrial Proximity Interaction Network.

ATP5PO USP11 GATB FLG2 SPTBN5 GK ALMS1 SLAIN1 CKAP4 GNAS HERC2 HERC1 PHIP WDR36 NUP107 RBM33 PCLO UBR4 BIRC2 FAM83B NCOA5 JPH1 VPS13D UTP18 FIGNL1 EXOC4

6.44e-0614962282632877691
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

KDM3B SAV1 KLHL9 ALMS1 CKAP4 RUSF1 SLC27A4 RBM33 JPH1 CCDC88A DDHD1 TTLL4 KIRREL1 ROBO1 AKAP13 CEP295 ELP4

7.97e-067332281734672954
Pubmed

Impairment in renal medulla development underlies salt wasting in Clc-k2 channel deficiency.

CLCNKA CLCNKB SLC12A1

9.55e-067228334499620
Pubmed

Intrarenal and cellular localization of CLC-K2 protein in the mouse kidney.

CLCNKA CLCNKB SLC12A1

9.55e-067228311423561
Pubmed

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

TAB2 POM121 ALMS1 SVIL NUP107 RBM33 FAM83B CCDC88A KIRREL1 EXOC4

1.04e-052632281034702444
Pubmed

Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.

THSD4 IL16 PDE4B SWT1 ZNF236 COBL POU2F1 LINGO2 ROBO2 UNC13C

1.11e-052652281019240061
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

GATAD2A KDM3B MYSM1 KMT2A ZNF770 MLLT6 HERC2 PHIP HOMEZ NPAT KDM5A RBBP5 ADNP2 POU2F1 ZNF292

1.34e-056082281536089195
Pubmed

Trio GEF mediates RhoA activation downstream of Slit2 and coordinates telencephalic wiring.

EBF1 ROBO1 ROBO2

1.52e-058228330177526
Pubmed

Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.

RELN LGALS9B COL6A5 COL24A1 PXDN LAMA4 LGALS9 MUC4

2.19e-05175228828071719
Pubmed

Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression.

KMT2A RBBP5 UTP18

2.27e-059228315199122
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

PDE4B ARHGAP15 TAB2 CLCNKA ADAMTS18 CRYBG1 HERC1 ARHGEF6 RAD17 NPAT CACNB2 FAM210A MPEG1 CUBN SEC24C DDHD1 SIPA1L1 TTLL4 OR10AD1 CEP295

3.49e-0510842282011544199
Pubmed

CR3 and Dectin-1 Collaborate in Macrophage Cytokine Response through Association on Lipid Rafts and Activation of Syk-JNK-AP-1 Pathway.

CLEC7A C3

4.28e-052228226132276
Pubmed

The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron.

CLCNKA CLCNKB

4.28e-052228227335120
Pubmed

Assignment of the genes encoding the human chloride channels, CLCNKA and CLCNKB, to 1p36 and of CLCN3 to 4q32-q33 by in situ hybridization.

CLCNKA CLCNKB

4.28e-05222828812470
Pubmed

Robo signaling regulates the production of cranial neural crest cells.

ROBO1 ROBO2

4.28e-052228228987541
Pubmed

Associations between CLCNKA_B tag SNPs with essential hypertension and interactions between genetic and environmental factors in an island population in China.

CLCNKA CLCNKB

4.28e-052228225919862
Pubmed

NTPDase2 and the P2Y1 receptor are not required for mammalian eye formation.

P2RY1 ENTPD2

4.28e-052228225504514
Pubmed

Distribution of voltage-dependent calcium channel beta subunits in the hippocampus of patients with temporal lobe epilepsy.

CACNB1 CACNB2

4.28e-052228210465427
Pubmed

A Spatiotemporal Sequence of Sensitization to Slits and Semaphorins Orchestrates Commissural Axon Navigation.

ROBO1 ROBO2

4.28e-052228231597096
Pubmed

Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss.

CLCNKA CLCNKB

4.28e-052228238069401
Pubmed

Critical role of Lama4 for hematopoiesis regeneration and acute myeloid leukemia progression.

KMT2A LAMA4

4.28e-052228234958665
Pubmed

Expression of mKirre in the developing sensory pathways: its close apposition to nephrin-expressing cells.

KIRREL3 KIRREL1

4.28e-052228218022324
Pubmed

Relative contributions of dectin-1 and complement to immune responses to particulate β-glucans.

CLEC7A C3

4.28e-052228222649195
Pubmed

Differential plasma membrane targeting of voltage-dependent calcium channel subunits expressed in a polarized epithelial cell line.

CACNB1 CACNB2

4.28e-052228210066897
Pubmed

A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels.

CLCNKA CLCNKB

4.28e-052228220805576
Pubmed

Robo1/2 regulate follicle atresia through manipulating granulosa cell apoptosis in mice.

ROBO1 ROBO2

4.28e-052228225988316
Pubmed

Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.

MUC16 MUC4

4.28e-052228223544943
Pubmed

Roundabout controls axon crossing of the CNS midline and defines a novel subfamily of evolutionarily conserved guidance receptors.

ROBO1 ROBO2

4.28e-05222829458045
Pubmed

Molecular heterogeneity of calcium channel beta-subunits in canine and human heart: evidence for differential subcellular localization.

CACNB1 CACNB2

4.28e-052228214762176
Pubmed

Salt wasting and deafness resulting from mutations in two chloride channels.

CLCNKA CLCNKB

4.28e-052228215044642
Pubmed

Two highly homologous members of the ClC chloride channel family in both rat and human kidney.

CLCNKA CLCNKB

4.28e-05222828041726
Pubmed

Association of SLC28A3 Gene Expression and CYP2B6*6 Allele with the Response to Fludarabine Plus Cyclophosphamide in Chronic Lymphocytic Leukemia Patients.

CYP2B6 SLC28A3

4.28e-052228230778771
Pubmed

An ancient founder mutation located between ROBO1 and ROBO2 is responsible for increased microtia risk in Amerindigenous populations.

ROBO1 ROBO2

4.28e-052228235584116
Pubmed

A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane.

CLCNKA CLCNKB

4.28e-052228218648499
Pubmed

Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney.

CLCNKA CLCNKB

4.28e-05222828544406
Pubmed

Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes.

CLCNKA CLCNKB

4.28e-052228224863058
Pubmed

Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel.

CLCNKA CLCNKB

4.28e-05222829916798
Pubmed

Kidney kinetics and chloride ion pumps.

CLCNKA CLCNKB

4.28e-05222829916791
Pubmed

Cell adhesion molecule KIRREL1 is a feedback regulator of Hippo signaling recruiting SAV1 to cell-cell contact sites.

SAV1 KIRREL1

4.28e-052228235177623
Pubmed

Robo1 and Robo2 are homophilic binding molecules that promote axonal growth.

ROBO1 ROBO2

4.28e-052228212504588
Pubmed

Endocrine cell type sorting and mature architecture in the islets of Langerhans require expression of Roundabout receptors in β cells.

ROBO1 ROBO2

4.28e-052228230022126
Pubmed

ANGPTL4 regulates CD163 expression and Kuppfer cell polarization induced cirrhosis via TLR4/NF-κB pathway.

CD163 ANGPT4

4.28e-052228234146541
Pubmed

Targeting tetramer-forming GABPβ isoforms impairs self-renewal of hematopoietic and leukemic stem cells.

GABPB2 GABPB1

4.28e-052228222862946
Pubmed

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes.

ROBO1 ROBO2

4.28e-052228226608094
Pubmed

Differential regulation of oxidative burst by distinct β-glucan-binding receptors and signaling pathways in human peripheral blood mononuclear cells.

CLEC7A C3

4.28e-052228224440830
Pubmed

Frameshift mutations of axon guidance genes ROBO1 and ROBO2 in gastric and colorectal cancers with microsatellite instability.

ROBO1 ROBO2

4.28e-052228224247621
Pubmed

ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits.

ALMS1 CEP295

4.28e-052228230421101
Pubmed

Cl(-) channels in basolateral TAL membranes XV. Molecular heterogeneity between cortical and medullary channels.

CLCNKA CLCNKB

4.28e-052228211014860
Pubmed

A genome-wide association study identifies protein quantitative trait loci (pQTLs).

KIRREL3 STARD9 CACNB2 ROBO1 ROBO2

5.11e-0561228518464913
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

SLC39A9 TAB2 KLHL9 ALMS1 SVIL COBL HERC2 DYNC2I2 RNF135 NUP43 FAM83B GRIP1 CCDC88A WASF2 SIPA1L1 CEP295 EXOC4

5.39e-058532281728718761
Pubmed

Genetic dissection of sodium and potassium transport along the aldosterone-sensitive distal nephron: importance in the control of blood pressure and hypertension.

CLCNKA NR3C2 SLC12A1

5.86e-0512228323684652
Pubmed

Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.

KLHL9 STARD9 NAV2 ARHGAP20 UNC79 HOMEZ UBR4

7.15e-05153228710718198
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

CDK19 ARHGEF17 CSMD3 KIRREL3 PXDN STARD9 COBL PHF6 SEC24C SIPA1L1 RUBCN

8.69e-054072281112693553
Pubmed

A human MAP kinase interactome.

DLGAP1 POM121 NAV2 COBL HERC2 RBM33 ADNP2 LAMA4 USF3 CCDC88A ROBO1 AKAP13

9.81e-054862281220936779
Pubmed

Voltage-activated calcium channel expression profiles in mouse brain and cultured hippocampal neurons.

CACNA1E CACNB1 CACNB2

1.19e-0415228320188150
Pubmed

Differential neuronal targeting of a new and two known calcium channel β4 subunit splice variants correlates with their regulation of gene expression.

CACNA1E CACNB1 CACNB2

1.19e-0415228324453333
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

CABLES1 PIK3R4 NAV2 KMT2A COBL HERC1 RBM33 VPS13D IGHMBP2 MUC4 SH3RF3 ZNF292

1.21e-044972281236774506
Pubmed

Robo family of proteins exhibit differential expression in mouse spinal cord and Robo-Slit interaction is required for midline crossing in vertebrate spinal cord.

ROBO1 ROBO2

1.28e-043228215768400
Pubmed

Human CLC-K Channels Require Palmitoylation of Their Accessory Subunit Barttin to Be Functional.

CLCNKA CLCNKB

1.28e-043228226013830
Pubmed

Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation.

LGALS9B LGALS9

1.28e-043228219776007
Pubmed

Cytoplasmic and nuclear interaction between Rb family proteins and PAI-2: a physiological crosstalk in human corneal and conjunctival epithelial cells.

RBL2 SERPINB2

1.28e-043228216397580
Pubmed

Lrp12/Mig13a reveals changing patterns of preplate neuronal polarity during corticogenesis that are absent in reeler mutant mice.

RELN LRP12

1.28e-043228220439316
Pubmed

Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.

MUC16 MUC4

1.28e-043228223053434
Pubmed

Galectin-9 regulates follicular helper T cells to inhibit humoral autoimmunity-induced pulmonary fibrosis.

LGALS9B LGALS9

1.28e-043228233316546
Pubmed

Barttin increases surface expression and changes current properties of ClC-K channels.

CLCNKA CLCNKB

1.28e-043228212111250
Pubmed

Rig-1 a new member of Robo family genes exhibits distinct pattern of expression during mouse development.

ROBO1 ROBO2

1.28e-043228214678835
Pubmed

Dynamic expression patterns of Robo (Robo1 and Robo2) in the developing murine central nervous system.

ROBO1 ROBO2

1.28e-043228214689480
Pubmed

Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin.

LGALS9B LGALS9

1.28e-04322829038233
Pubmed

Human placental multipotent mesenchymal stromal cells modulate placenta angiogenesis through Slit2-Robo signaling.

ROBO1 ROBO2

1.28e-043228226745454
Pubmed

Slit2-Robo Signaling Promotes Glomerular Vascularization and Nephron Development.

ROBO1 ROBO2

1.28e-043228234341180
Pubmed

Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production.

LGALS9B LGALS9

1.28e-043228228704475
Pubmed

Robos are required for the correct targeting of retinal ganglion cell axons in the visual pathway of the brain.

ROBO1 ROBO2

1.28e-043228218272390
Pubmed

Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.

MUC16 MUC4

1.28e-043228230236127
Pubmed

Common genetic variants and haplotypes in renal CLCNKA gene are associated to salt-sensitive hypertension.

CLCNKA CLCNKB

1.28e-043228217510212
Pubmed

Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis.

LGALS9B LGALS9

1.28e-043228223836896
Pubmed

Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes.

LGALS9B LGALS9

1.28e-04322827890611
Pubmed

Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner.

LGALS9B LGALS9

1.28e-043228222341088
Pubmed

Galectin-9 Is a Novel Regulator of Epithelial Restitution.

LGALS9B LGALS9

1.28e-043228232380082
Pubmed

Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts.

LGALS9B LGALS9

1.28e-043228223667648
Pubmed

Structural basis for the requirement of additional factors for MLL1 SET domain activity and recognition of epigenetic marks.

KMT2A RBBP5

1.28e-043228219187761
Pubmed

Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.

LGALS9B LGALS9

1.28e-043228228877989
Pubmed

Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages.

LGALS9B LGALS9

1.28e-043228219800850
Pubmed

The effect of Toxoplasma gondii infection on galectin-9 expression in decidual macrophages contributing to dysfunction of decidual NK cells during pregnancy.

LGALS9B LGALS9

1.28e-043228238987795
Pubmed

ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling.

ROBO1 ROBO2

1.28e-043228230504844
Pubmed

Alternative splicing of the Robo3 axon guidance receptor governs the midline switch from attraction to repulsion.

ROBO1 ROBO2

1.28e-043228218466743
Pubmed

Histone lysine demethylases in breast cancer.

KDM3B KDM5A

1.28e-043228223266085
Pubmed

Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.

LGALS9B LGALS9

1.28e-043228237105392
Pubmed

Allelic-based gene-gene interaction associated with quantitative traits.

CLCNKB SLC12A1

1.28e-043228219058262
Pubmed

Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson's disease.

LGALS9B LGALS9

1.28e-043228236479526
Pubmed

Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans.

CLEC7A C3

1.28e-043228221531981
Pubmed

Profiling Lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy.

LGALS9B LGALS9

1.28e-043228223242525
Pubmed

Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice.

LGALS9B LGALS9

1.28e-043228219851072
Pubmed

The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes.

LGALS9B LGALS9

1.28e-043228233923930
InteractionYWHAH interactions

DLGAP1 KDM3B SAV1 TAB2 ARHGEF17 SHKBP1 PIK3R4 KCNQ5 ALMS1 STARD9 SVIL NAV2 KMT2A COBL SLAIN1 NR3C2 HERC1 ARHGEF6 HOMEZ KDM5A RAB11FIP1 CDC14A FAM83B GRIP1 VPS13D CCDC88A WASF2 SIPA1L1 AKAP13 SH3RF3 PLK4 RUBCN SAMD4A EXOC4

5.66e-08110222334int:YWHAH
InteractionYWHAG interactions

DLGAP1 RC3H1 KDM3B TAB2 ARHGEF17 SHKBP1 PIK3R4 KCNQ5 ALMS1 STARD9 SVIL NAV2 KMT2A COBL SLAIN1 GNAS ARHGEF6 HOMEZ RAB11FIP1 CDC14A FAM83B GRIP1 VPS13D CCDC88A WASF2 SIPA1L1 AKAP13 SH3RF3 PLK4 RUBCN SAMD4A EXOC4

7.78e-06124822332int:YWHAG
GeneFamilyWD repeat domain containing

SHKBP1 PIK3R4 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4

1.14e-0626216913362
GeneFamilyCD molecules|Mucins

MUC21 MUC16 MUC3A MUC4

3.89e-05211694648
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

IGSF10 KIRREL3 PXDN SIGLEC12 LINGO2 KIRREL1 ROBO1 ROBO2

1.38e-041611698593
GeneFamilySolute carriers

SLC39A9 SLC28A3 SLC15A3 SLC41A2 SLC35D3 SLC5A12 SLC27A4 SLC26A3 SLC12A1 SLC26A7 SLC18A1 SLCO1A2

3.50e-0439516912752
GeneFamilyWD repeat domain containing|UTPB complex

WDR36 UTP18

1.27e-03616921225
GeneFamilyCalcium voltage-gated channel subunits

CACNA1E CACNB1 CACNB2

1.78e-03261693253
GeneFamilyC2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors

CLEC7A CD163 SCARA3

1.99e-032716931253
GeneFamilyZinc fingers AN1-type|UPF1 like RNA helicases

ZFAND4 IGHMBP2

2.34e-038169263
GeneFamilyNucleoporins

POM121 NUP107 NUP43

3.26e-033216931051
GeneFamilyChloride voltage-gated channels

CLCNKA CLCNKB

3.72e-03101692302
GeneFamilyRing finger proteins

TRIML1 RC3H1 RNF13 RNF19A RNF135 BIRC2 RNF6 SH3RF3

4.40e-03275169858
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

INPP4A PCLO RAB11FIP1

4.57e-03361693823
CoexpressionBUSSLINGER_GASTRIC_IMMUNE_CELLS

IL16 PDE4B ARHGAP15 INPP4A TAB2 INO80D MYSM1 NXPE3 NEDD9 KMT2A CRYBG1 MLLT6 GNAS HERC1 PHIP ARHGEF6 NSMAF NPAT PLAAT4 KDM5A RNF19A RBM33 RBL2 UBR4 BIRC2 CDC14A HIVEP3 CCDC88A IPCEF1 AKAP13 ZNF292

4.79e-06149222531M40023
CoexpressionZHONG_PFC_C3_ASTROCYTE

NEXMIF KMT2A ARHGAP20 UNC79 CACNA1E CACNB1 RBM33 PCLO TMEM151B SEC31B MAMDC4 IGHMBP2 MYO16 MAPK8IP2

7.62e-0638922514M39102
CoexpressionLEE_DIFFERENTIATING_T_LYMPHOCYTE

ARHGAP15 INPP4A ALMS1 ARHGEF6 KDM5A RBM33 SEC31B USF3 IPCEF1 AKAP13

1.01e-0520122510M2200
CoexpressionDESCARTES_FETAL_STOMACH_MUC13_DMBT1_POSITIVE_CELLS

GK KHK SLC5A12 MGAM2 SLC26A3 MAMDC4 MUC3A

2.09e-05972257M40301
CoexpressionNABA_MATRISOME

THSD4 RELN MUC21 IL16 LGALS9B CLEC7A COL6A5 FLG2 IGSF10 COL24A1 ANOS1 PXDN ANGPT4 ADAMTS18 CLEC10A TSPEAR LAMA4 MUC16 LGALS9 SERPINB2 MUC3A MUC4 SERPINA5

2.78e-05102622523M5889
CoexpressionGSE14308_TH17_VS_INDUCED_TREG_UP

INO80D CRYBG1 LRP12 KDM5A RNF19A VPS26B PHF6 PIGZ USF3

6.15e-052002259M3385
CoexpressionGSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP

METTL3 NEDD9 NXF2 KMT2A CRYBG1 HERC1 SLC27A4 RBL2 UBR4

6.15e-052002259M387
CoexpressionGSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_DN

DLGAP1 CYP2B6 PDE4B ATP5PO NXPE3 C3 MLLT6 RAB11FIP1 PIK3R6

6.15e-052002259M9861
CoexpressionGSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP

KDM3B SLC15A3 KCNQ5 NR3C2 RNF19A RBBP5 BIRC2 HIVEP3 TMEM63A

6.15e-052002259M7529
CoexpressionGSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN

SLC15A3 NXPE3 GK GSDME CACNA1E RNF135 ADNP2 MUC16 CD300LD

6.15e-052002259M5271
CoexpressionGSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP

SLC28A3 SHKBP1 IGSF10 CACNB1 RNF135 CDC14A LGALS9 SEC24C RUBCN

6.15e-052002259M6514
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DLGAP1 COL6A5 IGSF10 ARHGAP20 SCARA3 CACNB2 FAT3 LAMA4 ROBO1 MYO16

5.82e-08192227103d0cb19f037f604253d7d728689aeaa94251e92b
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP15 CLEC7A SLC15A3 CD163 GK CLEC10A MUC16 PIK3R6 CD300E

2.60e-07172227972fbfa890995e47048b47199c170cc7dcd7661f8
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP15 CLEC7A SLC15A3 CD163 GK CLEC10A MUC16 PIK3R6 CD300E

2.60e-0717222792ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea
ToppCellLPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL6A5 IGSF10 ANOS1 COBL ARHGAP20 CACNB2 AKAP13 MYO16 EXOC4

3.32e-071772279b7fee75de7e96924af488a5baa2334711889ae7c
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

DLGAP1 IL16 COL6A5 IGSF10 CACNB2 FAT3 LAMA4 ROBO1 ROBO2

4.00e-0718122799ede19228ba5c0668a9c06c915510b95585216ef
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELN CSMD3 COL24A1 UNC79 FAT3 PCLO ROBO1 UNC13C MYO16

4.60e-0718422792cbed6462fea2622871bb7e49b0df3d984239281
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

DLGAP1 ARHGAP15 SVIL C3 CDC14A IPCEF1 AKAP13 SAMD4A TMEM63A

4.60e-071842279d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELN CSMD3 COL24A1 UNC79 FAT3 PCLO ROBO1 UNC13C MYO16

4.60e-0718422792b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELN CSMD3 COL24A1 UNC79 FAT3 PCLO ROBO1 UNC13C MYO16

4.60e-071842279ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DLGAP1 CSMD3 IGSF10 ARHGAP20 CACNB2 FAT3 LAMA4 ROBO2 UNC13C

5.76e-071892279203c80030df08ae112f9ae4043709f455d87ce89
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 SVIL NAV2 LAMA4 HIVEP3 SLC12A1 IPCEF1 KIRREL1 SAMD4A

5.76e-0718922798c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PDE4B ARHGAP15 CLEC7A CD163 GK ARHGEF6 PIK3R6 SIPA1L1 CD300E

5.76e-0718922797ccea2df93bb4b37417bbc8f6c85a61ece95211a
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NEDD9 SVIL NAV2 LAMA4 HIVEP3 SLC12A1 IPCEF1 KIRREL1 SAMD4A

5.76e-0718922795d902a4660a27548764bf04c6de152b565da835c
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN KIRREL3 ANOS1 ADARB2-AS1 IRX6 GRIP1 KIRREL1 UNC13C MYO16

6.02e-071902279be2b184a3559da41ba387ae0fdbeb9ae532868a5
ToppCellControl-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

THSD4 DLGAP1 COL6A5 IGSF10 ARHGAP20 SCARA3 CACNB2 FAT3 MYO16

6.29e-07191227914057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

DLGAP1 IL16 NAV2 CACNB2 FAT3 LAMA4 HIVEP3 ROBO1 ROBO2

6.86e-07193227999525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCellLA|World / Chamber and Cluster_Paper

IL16 SLC41A2 KIRREL3 PXDN NAV2 C3 CACNA1E EBF1 ROBO1

6.86e-071932279d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell390C-Myeloid-Monocyte-CD14+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells)

PDE4B CLEC7A SLC15A3 CD163 GK CLEC10A MPEG1 SERPINB2 CD300E

6.86e-071932279a50ee6110ea272d9d9f41d48bb5d43711cc00a32
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

DLGAP1 IL16 NAV2 CACNB2 FAT3 LAMA4 HIVEP3 KIRREL1 ROBO2

7.16e-071942279e93de9428c986b8943fc169258847c650cfab0e5
ToppCellLPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DLGAP1 COL6A5 IGSF10 SCARA3 CACNB2 FAT3 LAMA4 ROBO1 MYO16

7.16e-0719422796e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DLGAP1 COL6A5 IGSF10 ARHGAP20 CACNB2 FAT3 LAMA4 ROBO1 MYO16

7.16e-07194227989b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DLGAP1 COL6A5 IGSF10 ARHGAP20 CACNB2 FAT3 LAMA4 ROBO1 MYO16

7.16e-07194227960622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor

IL16 IGSF10 NAV2 CACNB2 FAT3 LAMA4 EBF1 ROBO1 ROBO2

7.48e-071952279aa0add081881d349099d12efca5cdee098038d4e
ToppCell390C-Myeloid|390C / Donor, Lineage, Cell class and subclass (all cells)

CLEC7A CD163 GK CLEC10A ARHGEF6 MPEG1 LGALS9 CCDC88A CD300E

7.80e-0719622795b690062db162e9ddd1a32b1be4d10f5f99c9407
ToppCellCOVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type

IL16 COL6A5 NAV2 ARHGAP20 CACNB2 FAT3 LAMA4 ROBO1 ROBO2

8.49e-0719822793ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DLGAP1 CSMD3 KCNQ5 HERC1 UNC79 PCLO LINGO2 GRIP1 ROBO2

8.49e-0719822790ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCellbackground-Kupffer_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

PDE4B CLEC7A SLC15A3 INO80D CD163 C3 SLC26A3 MPEG1 LGALS9

8.85e-07199227991d229f3515d49639bcb5505e6aec4a9abade81c
ToppCell356C-Myeloid|356C / Donor, Lineage, Cell class and subclass (all cells)

CLEC7A SLC15A3 CD163 GK CLEC10A MPEG1 LGALS9 CCDC88A CD300E

8.85e-071992279aca97ade3e4cc528315fa327e74a6245300f7b8c
ToppCellcontrol-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CLEC7A SLC15A3 CD163 CKAP4 UBR4 MPEG1 RAB11FIP1 CCDC88A CD300E

9.23e-072002279b5d197472799cc61d7497faed91ac2564ae4930a
ToppCellBronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

IL16 NAV2 CACNB2 FAT3 LAMA4 EBF1 ROBO1 ROBO2 SH3RF3

9.23e-072002279cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCellfacs-Marrow-B-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC7A SLC28A3 FLG2 MPEG1 PIGZ PIK3R6 CD300E PROS1

1.49e-0615722780966e347f8d32b13f8a3b3afba3f64637c69cdf9
ToppCellfacs-Marrow-B-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC7A SLC28A3 FLG2 MPEG1 PIGZ PIK3R6 CD300E PROS1

1.49e-0615722786ebfedd91d62c6d4aa8f046657a899a279f82ba2
ToppCell3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ZNF236 NEDD9 SPTBN5 VSIG10L NAV2 FAM83B IPCEF1 SAMD4A

1.80e-0616122780d863d7d369391dd6148e1de6d6f8033dcb8fe0f
ToppCellfacs-MAT-Fat-3m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC7A CD163 CLEC10A ARHGEF6 MPEG1 RAB11FIP1 CCDC88A PIK3R6

2.06e-061642278b81498c3934e0d52bf0329dc745e02966f9d8613
ToppCellfacs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CSMD3 COL24A1 UNC79 FAT3 PCLO CUBN SLC18A1 UNC13C

2.58e-06169227812bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGEF17 ANOS1 KCNQ5 GNAS CACNB2 GPR20 EBF1 ROBO1

2.69e-061702278cdb6fad277f284c3fd5a6f45672a8edc24715882
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGEF17 ANOS1 KCNQ5 GNAS CACNB2 GPR20 EBF1 ROBO1

2.69e-06170227899dd734c0972a40d5381e8e2d96bdaa31f6d06e6
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGEF17 ANOS1 KCNQ5 GNAS CACNB2 GPR20 EBF1 ROBO1

2.69e-0617022783a14eeae221b8bb0bd0dadcb8e7a603431240a1e
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDE4B ARHGAP15 INPP4A FCHO1 COL24A1 MPEG1 RAB11FIP1 CCDC88A

2.81e-061712278af1c93eb75f45c042ea475d93db56e4da207e31f
ToppCelldroplet-Fat-BAT+GAT+MAT-30m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDE4B CLEC7A SLC15A3 CD163 CLEC10A ARHGEF6 MPEG1 CCDC88A

2.94e-0617222786b01448443cf8392ed8248ff452b80c31240b85d
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PDE4B ARHGAP15 CLEC7A CD163 CLEC10A MPEG1 CCDC88A MAPK8IP2

2.94e-061722278f6b4754a7e4b3e38030316a0ae00d932bfa87e41
ToppCelldroplet-Fat-BAT+GAT+MAT-30m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDE4B CLEC7A SLC15A3 CD163 CLEC10A ARHGEF6 MPEG1 CCDC88A

2.94e-0617222780c0ae2da3cba6022403434567800f16e61a34a2b
ToppCelldroplet-Fat-BAT+GAT+MAT-30m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDE4B CLEC7A SLC15A3 CD163 CLEC10A ARHGEF6 MPEG1 CCDC88A

2.94e-061722278d80c207f3489be2da2f40f47a7835cb73c949c3e
ToppCellChildren_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

COL24A1 KCNQ5 SCARA3 CACNB2 ROBO1 ROBO2 UNC13C SH3RF3

3.07e-0617322781f16d47f5548e257e4b17f8070c5619780a9c5fd
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9

CSMD3 INO80D KMT2A MLLT6 HERC1 POU2F1 VPS13D SLCO1A2

3.64e-061772278e8ab340b20cd41554c3841fe980e078e878af35f
ToppCellGlobus_pallidus|World / BrainAtlas - Mouse McCarroll V32

SHKBP1 SLC35D3 MLLT6 SZT2 P2RY1 UNC13C MUC3A

3.85e-06126227744b63f945d5bedf1a2ca1810e7e100276ea9dd89
ToppCellCOVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type

RELN KIRREL3 PXDN C3 TMEM151B LAMA4 EBF1 KIRREL1

3.95e-061792278e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DLGAP1 COL6A5 IGSF10 ARHGAP20 CACNB2 FAT3 HIVEP3 MYO16

4.12e-06180227808ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCellChildren_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

COL24A1 KCNQ5 SCARA3 CACNB2 ROBO1 ROBO2 UNC13C SH3RF3

4.12e-06180227801f2e5d96016823482f89ba503d007d4bd88eeac
ToppCellChildren_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

MUC21 CYP2B6 NEXMIF SLC41A2 NAV2 GRIP1 ROBO2 MUC4

4.12e-061802278b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

GK KHK CACNB2 SLC26A3 FAT3 CUBN SLC12A1 ROBO2

4.29e-061812278c80ffa2ded5975a88e9a1a7d333196f95237bf0a
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

RELN KIRREL3 NR3C2 LINGO2 KRT79 P2RY1 ROBO1

4.74e-06130227760e28d452d0e2af768459ba8dbe998117c94a251
ToppCelldroplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC7A SLC15A3 KLHL9 LRP12 MPEG1 KRT79 DDHD1 PROS1

5.24e-0618622788f77e552e613b6e124443c7f6ef5c1316a5ff8db
ToppCelldroplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC7A SLC15A3 KLHL9 LRP12 MPEG1 KRT79 DDHD1 PROS1

5.24e-061862278f1aa0c58336d23bcbe52a59e7af954d20085bdb6
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor

DLGAP1 COL6A5 NAV2 ARHGAP20 CACNB2 LAMA4 ROBO1 ROBO2

5.45e-061872278e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCellControl-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations)

IL16 COL24A1 CACNB2 FAT3 LAMA4 ROBO1 ROBO2 SH3RF3

5.45e-061872278bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCellFetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

THSD4 COL24A1 SCARA3 CACNB2 ROBO1 ROBO2 UNC13C SH3RF3

5.45e-061872278c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN ANOS1 GSDME ADARB2-AS1 GRIP1 ROBO1 ROBO2 MYO16

5.67e-061882278433a25fe52914e07e7ba695881f9bcca2d9467ff
ToppCell10x_5'_v1-Non-neoplastic-Myeloid-Mono|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CLEC7A CD163 GK CKAP4 CLEC10A MPEG1 SERPINB2 CD300E

5.67e-061882278fbf176b48b89c234e4e1e64739afc836bed78a96
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL6A5 ARHGAP20 SCARA3 CACNB2 HIVEP3 ROBO1 MYO16 SAMD4A

6.13e-06190227845df8fee00f8949937863159d7aa042e72748d9b
ToppCellControl-Fibroblasts|Control / group, cell type (main and fine annotations)

IL16 CACNB2 FAT3 LAMA4 EBF1 ROBO1 ROBO2 SH3RF3

6.13e-0619022783a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 ARHGAP15 NAV2 ARHGAP20 LAMA4 EBF1 ROBO1 SH3RF3

6.37e-061912278a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DLGAP1 COL6A5 IGSF10 CACNB2 FAT3 LAMA4 ROBO1 MYO16

6.37e-061912278b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 ARHGAP15 NAV2 ARHGAP20 LAMA4 EBF1 ROBO1 SH3RF3

6.37e-0619122788f6d592edc32fdb901af30501d4360512334e8c2
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

DLGAP1 NEDD9 ADAMTS18 PHIP KDM5A RBM33 ROBO1 ZNF292

6.62e-061922278916fbec1c7ab7969bda711886ac88e877e30c280
ToppCellPBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CLEC7A SLC15A3 CD163 CKAP4 MPEG1 ZMIZ1 CCDC88A CD300E

6.62e-0619222780219093e7921a0db78053aee13ec480b520f5662
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DLGAP1 COL6A5 IGSF10 ARHGAP20 CACNB2 FAT3 ROBO1 MYO16

6.62e-0619222786f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DLGAP1 COL6A5 SCARA3 CACNB2 HIVEP3 ROBO1 MYO16 SAMD4A

6.62e-061922278df1545670370fb1010c567cd059c2783eab315f7
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

GATAD2A SLC41A2 SVIL COBL AKAP13 CD300E SH3RF3 SAMD4A

6.62e-0619222788b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN ANOS1 ADARB2-AS1 ZFAND4 GRIP1 KIRREL1 UNC13C MYO16

6.62e-061922278bd3fa6c8fcb618db64d11f25cabaf08608957c35
ToppCellE18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|E18.5-samps / Age Group, Lineage, Cell class and subclass

THSD4 HDX ALMS1 MLLT6 UNC79 SCARA3 P2RY1

6.69e-061372277b553958e7e6dcd887d860e34d3983cbb85cefaa6
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGAP15 CLEC7A FCHO1 C3 CLEC10A MPEG1 CCDC88A PIK3R6

6.87e-0619322783e3d7cb3e7242ec9c9677e07e303835649852b52
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

DLGAP1 NEDD9 ADAMTS18 PHIP KDM5A RBM33 ROBO1 ZNF292

6.87e-061932278e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DLGAP1 COL6A5 IGSF10 ARHGAP20 CACNB2 FAT3 ROBO1 MYO16

6.87e-061932278fb28717fadd06c3840636d25409ce80c9254bd34
ToppCellMesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor

DLGAP1 ARHGAP20 CACNB2 FAT3 LAMA4 ROBO1 ROBO2 UNC13C

6.87e-061932278acad568621ed677031797b8c2e34dafea798d681
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DLGAP1 CSMD3 ARHGAP20 CACNB2 FAT3 LAMA4 ROBO2 UNC13C

7.14e-061942278011e14d9ed1393275f892060e7708ffadcd0767f
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 COBL CRYBG1 NR3C2 RAB11FIP1 FAM83B GRIP1 AKAP13

7.14e-06194227846070fbb0ee0eb9e1801c43b73a15707471056dc
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

THSD4 COBL CRYBG1 NR3C2 RAB11FIP1 FAM83B GRIP1 AKAP13

7.14e-061942278abacb6a8d7a9003f2f6c2be0305507f1c1c50347
ToppCellMS-granulo1-|MS / Condition, Cell_class and T cell subcluster

CLEC7A CD163 CLEC10A RNF135 MPEG1 LGALS9 CCDC88A CD300E

7.41e-061952278eeaa2ecbcfbfb203c77261367b43ce55e786b312
ToppCell343B-Myeloid-Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells)

PDE4B CLEC7A CD163 GK CLEC10A MPEG1 SERPINB2 CD300E

7.41e-061952278169b4952118ca5ded55de928a1cf08721cdac193
ToppCellCOVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type

PDE4B ARHGAP15 CLEC7A CD163 GK CCDC88A SIPA1L1 CD300E

7.41e-061952278148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCellPBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CLEC7A SLC15A3 CD163 CKAP4 MPEG1 RAB11FIP1 CCDC88A CD300E

7.41e-0619522780110b976f98561ecd2e20ff6e7e3960a401bb7c2
ToppCell390C-Myeloid-Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells)

CLEC7A SLC15A3 CD163 GK MPEG1 LGALS9 SERPINB2 CD300E

7.41e-0619522786f09bfd6394c10c90c23d130a18941bf490e1a8f
ToppCell367C-Myeloid-Monocyte-CD14+_Monocyte|367C / Donor, Lineage, Cell class and subclass (all cells)

PDE4B CLEC7A CD163 GK CLEC10A MPEG1 SERPINB2 CD300E

7.41e-0619522784f9e26e033353fc9a8bdbd10358ee68ab2291880
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor

IL16 COL6A5 NAV2 CACNB2 FAT3 LAMA4 ROBO1 ROBO2

7.41e-06195227861c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCellMS-granulo1|MS / Condition, Cell_class and T cell subcluster

CLEC7A CD163 CLEC10A RNF135 MPEG1 LGALS9 CCDC88A CD300E

7.41e-06195227829688f55a6cdefbff4e818c20cb89473fbc16a59
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RELN ANOS1 ADARB2-AS1 ZFAND4 GRIP1 KIRREL1 UNC13C MYO16

7.41e-06195227898ca9f3aa36211dde1e6f7f3817b9418c95e583e
ToppCellPBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CLEC7A SLC15A3 CD163 CKAP4 MPEG1 RAB11FIP1 CCDC88A CD300E

7.41e-061952278050fc59b328391d6e3ce23051764a842dcbb3144
ToppCellMonocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

CLEC7A SLC15A3 CD163 CLEC10A MPEG1 LGALS9 CCDC88A CD300E

7.69e-061962278ab0a8f5f388c9794d7f41f99fb0a5f2fd6fff6b3
ToppCellCOVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations)

PDE4B CLEC7A RNF13 CD163 GK CCDC88A SIPA1L1 CD300E

7.69e-0619622784929cfed1f150c1fde4d79cb49895c2ea467a18f
ToppCell(3)_MNP|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

CLEC7A SLC15A3 CD163 CLEC10A MPEG1 LGALS9 CCDC88A CD300E

7.69e-061962278c79403da5443710a6caf035a279e42bc324b27c9
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

COL24A1 ARHGAP20 CACNB2 FAT3 LAMA4 ROBO1 ROBO2 UNC13C

7.69e-0619622781450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCellChildren_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor

DLGAP1 IL16 IGSF10 CACNB2 FAT3 LAMA4 EBF1 ROBO2

7.69e-061962278bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCelldistal-Hematologic-EREG+_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

PDE4B CLEC7A CD163 GK CLEC10A MPEG1 SIPA1L1 CD300E

7.69e-06196227814c6870d125fc2bdacf4199883399cec0dd3f569
ToppCellBronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations

THSD4 NAV2 NR3C2 SLC26A3 AMBRA1 HIVEP3 SIPA1L1 EXOC4

7.69e-061962278ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCelldistal-Hematologic-EREG+_Dendritic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

PDE4B CLEC7A CD163 GK CLEC10A MPEG1 SIPA1L1 CD300E

7.69e-061962278c17bb7b3992bfec194bfa310f201a5c64b35868e
ToppCellMonocytes-IL1B+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

CLEC7A CD163 GK CLEC10A MPEG1 LGALS9 CCDC88A CD300E

7.69e-0619622787bc0735d324ac5a1661434cda4116ddd58296730
ToppCell367C-Myeloid-Monocyte|367C / Donor, Lineage, Cell class and subclass (all cells)

PDE4B CLEC7A CD163 GK CLEC10A MPEG1 SERPINB2 CD300E

7.69e-061962278202066aeb837659fcc2e127fb52d7189e2e3520d
ToppCell(05)_Secretory|World / shred by cell type by condition

CYP2B6 COBL C3 PLAAT4 MUC16 RAB11FIP1 LGALS9 MUC4

7.69e-0619622788032c25b51ef96aeba28cc52686a2bd45213453d
ToppCellnucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

IL16 NAV2 CACNB2 FAT3 LAMA4 EBF1 ROBO1 ROBO2

7.69e-0619622787d8505dac15fa59935ccf592afc54b04c4c6554f
DiseaseColorectal Carcinoma

CSMD3 CABLES1 TXNRD1 KCNQ5 ADAMTS18 NR3C2 GNAS PHIP CACNB1 CACNB2 TSPEAR ZMIZ1 CUBN CDC14A HIVEP3 DUSP21 SLCO1A2 CD300E GABPB1 PROS1 ZNF292 EXOC4

2.39e-0870222422C0009402
Diseaseserum gamma-glutamyl transferase measurement

THSD4 HDX SLC28A3 CSMD3 FCHO1 POM121 CLCNKB SVIL NAV2 KMT2A C3 NSMAF UGT1A8 RNF135 EBF1 ZMIZ1 SLCO1A2 COMMD7 ROBO1 AKAP13 ZNF292 EXOC4

2.09e-0691422422EFO_0004532
DiseaseBartter syndrome

CLCNKA CLCNKB SLC12A1

8.49e-0662243cv:C0004775
Diseasediet measurement

PDE4B ARHGAP15 KDM3B SLC28A3 RNF13 KIRREL3 GSDME KCNQ5 SLC35D3 ZNF770 NR3C2 TSPEAR LINGO2 EBF1 TPK1 COMMD7 ROBO1 ROBO2 UNC13C MYO16 EXOC4

5.54e-05104922421EFO_0008111
DiseaseBartter disease type 4B

CLCNKA CLCNKB

5.74e-0522242cv:C4310805
DiseaseBartter disease type 3 (implicated_via_orthology)

CLCNKA CLCNKB

5.74e-0522242DOID:0110144 (implicated_via_orthology)
DiseaseBARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS

CLCNKA CLCNKB

5.74e-0522242613090
DiseaseBARTTER SYNDROME, TYPE 4B

CLCNKA CLCNKB

5.74e-0522242C2751312
DiseaseBARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS

CLCNKA CLCNKB

5.74e-0522242C4310805
DiseaseBartter disease type 4b (is_implicated_in)

CLCNKA CLCNKB

5.74e-0522242DOID:0110146 (is_implicated_in)
DiseaseBartter disease (implicated_via_orthology)

CLCNKA CLCNKB

5.74e-0522242DOID:445 (implicated_via_orthology)
Diseasebrain measurement, neuroimaging measurement

THSD4 NAV2 ADAMTS18 CACNB2 RBBP5 FAT3 RNF135 NUP43 PM20D1 COMMD7 ROBO1 ROBO2 SH3RF3 EXOC4

8.86e-0555022414EFO_0004346, EFO_0004464
Diseaseneuroticism measurement, cognitive function measurement

ARHGAP15 GATB FCHO1 NEDD9 NAV2 NR3C2 CACNA1E RBL2 PCLO PM20D1 NCOA5 SIPA1L1 GKAP1 EXOC4

1.20e-0456622414EFO_0007660, EFO_0008354
DiseaseGrowth abnormality

ZMIZ1 ZNF292

1.71e-0432242C0262361
DiseaseAmphetamine-Related Disorders

PDE4B LINGO2 CUBN SH3RF3 SERPINA5

2.70e-04752245C0236733
DiseaseAmphetamine Abuse

PDE4B LINGO2 CUBN SH3RF3 SERPINA5

2.70e-04752245C0236807
DiseaseAmphetamine Addiction

PDE4B LINGO2 CUBN SH3RF3 SERPINA5

2.70e-04752245C0236804
DiseaseCharcot-Marie-Tooth disease type 2

DNAJB2 JPH1 IGHMBP2

2.71e-04172243cv:C0270914
DiseaseFeeding difficulties

RNF13 ZMIZ1 ZNF292

3.24e-04182243C0232466
Diseaselepromatous leprosy (is_marker_for)

CD163 C3

3.41e-0442242DOID:10887 (is_marker_for)
Diseasecortical thickness

THSD4 RELN GATAD2A ANGPT4 NAV2 ADAMTS18 KMT2A FAT3 PM20D1 EBF1 GRIP1 VPS13D CCDC88A SLCO1A2 LRP11 ROBO1 ROBO2 SH3RF3 MYO16 EXOC4

3.46e-04111322420EFO_0004840
Diseaseneuroimaging measurement

THSD4 RELN GATAD2A COL24A1 NAV2 ADAMTS18 CACNB2 SZT2 RBBP5 FAT3 PM20D1 JPH1 CCDC88A LRP11 ROBO1 ROBO2 SH3RF3 MYO16 EXOC4

5.55e-04106922419EFO_0004346
DiseaseBartter Disease

CLCNKB SLC12A1

5.65e-0452242C0004775
Diseasepolybrominated biphenyl measurement, gestational serum measurement, polybrominated diphenyl ether measurement

DLGAP1 CYP2B6

5.65e-0452242EFO_0007961, EFO_0007962, EFO_0007964
DiseaseNeurodevelopmental Disorders

DLGAP1 NEXMIF KMT2A HIVEP3 ZNF292

7.29e-04932245C1535926
DiseaseAbnormal muscle tone

RNF13 ZNF292

8.43e-0462242C0852413
Diseaseobsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa

PDE4B KDM3B RBKS GSDME CACNB2 PCLO AMBRA1

8.77e-042002247EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351
Diseaseresponse to norepinephrine-dopamine reuptake inhibitor

KCNQ5 ROBO2 SAMD4A

9.86e-04262243EFO_0007870
Diseasemigraine disorder, type 2 diabetes mellitus

SLC28A3 EBF1 OR10AD1 DNAI4

1.13e-03602244MONDO_0005148, MONDO_0005277
Diseasemyoclonic-atonic epilepsy (implicated_via_orthology)

ROBO1 ROBO2

1.17e-0372242DOID:0060475 (implicated_via_orthology)
DiseaseX-21339 measurement

UGT1A8 SLCO1A2

1.17e-0372242EFO_0800808
Diseasetriacylglycerol 50:4 measurement

GATAD2A RBKS ZNF236

1.51e-03302243EFO_0010411
DiseaseAbnormality of the skeletal system

ZMIZ1 ZNF292

1.56e-0382242C4021790
DiseaseN2,N2-dimethylguanosine measurement

ALMS1 SH3RF3

1.56e-0382242EFO_0021125
Diseaselevel of Triacylglycerol (49:2) in blood serum

GATAD2A ADGRD2

1.56e-0382242OBA_2045162
DiseaseLymphoid leukemia

KMT2A IPCEF1

1.56e-0382242C0023448
Diseasereaction time measurement

GATAD2A CDK19 GATB SLC28A3 RBKS COL24A1 POM121 NAV2 SLC5A12 PM20D1 AMBRA1 TPK1 DNAI4

1.67e-0365822413EFO_0008393
DiseaseMicrocephaly

ZMIZ1 CCDC88A PLK4 ZNF292

1.70e-03672244C0025958
Diseaseeyelid sagging measurement

DLGAP1 KCNQ5 ADAMTS18

1.82e-03322243EFO_0009360
DiseaseLiver Diseases, Parasitic

GNAS ROBO2

1.99e-0392242C0023897
Diseasemarginal zone B-cell lymphoma, multiple sclerosis

ZMIZ1 NCOA5

1.99e-0392242EFO_1000630, MONDO_0005301
DiseaseIntellectual Disability

INPP4A KDM3B RNF13 KCNQ5 GNAS PHIP CACNA1E KDM5A ZMIZ1 ZNF292

2.33e-0344722410C3714756
DiseaseDDT metabolite measurement

CYP2B6 IGLV10-54 MUC16 CDC14A

2.46e-03742244EFO_0007886
Diseasenephrogenic diabetes insipidus (implicated_via_orthology)

CLCNKA CLCNKB

2.48e-03102242DOID:12387 (implicated_via_orthology)
DiseasePseudohypoaldosteronism, Type I

NR3C2 GNAS

2.48e-03102242C0268436
DiseasePseudohypoaldosteronism

NR3C2 GNAS

2.48e-03102242C0033805
Diseasetransverse temporal cortex volume measurement

P2RY1 UNC13C

2.48e-03102242EFO_0010336
DiseaseHyperpotassemia and Hypertension, Familial

NR3C2 GNAS

2.48e-03102242C2713447
DiseasePseudohypoaldosteronism, Type I, Autosomal Recessive

NR3C2 GNAS

2.48e-03102242C1449843
DiseasePseudohypoaldosteronism, Type II

NR3C2 GNAS

2.48e-03102242C1449844
DiseasePseudohypoaldosteronism, Type I, Autosomal Dominant

NR3C2 GNAS

2.48e-03102242C1449842
Diseaseblood urea nitrogen measurement

DLGAP1 RBKS CLCNKB GNAS RAD17 EBF1 CDC14A FAM83B ROBO1 AKAP13

2.53e-0345222410EFO_0004741
Diseaseintellectual disability (implicated_via_orthology)

GATAD2A KDM5A RBL2 UBR4

2.58e-03752244DOID:1059 (implicated_via_orthology)
Diseaseage at first sexual intercourse measurement

PDE4B ARHGAP15 GABPB2 UNC79 VPS26B AMBRA1 GABPB1 ZNF292 EXOC4

2.76e-033832249EFO_0009749
Diseasediverticulitis

ARHGAP15 TAB2 SVIL

2.77e-03372243EFO_1001460
Diseaseurate measurement, bone density

THSD4 ARHGAP15 RC3H1 COL6A5 NEDD9 KIRREL3 NR3C2 UGT1A8 RNF6 ROBO1 SH3RF3 MYO16

2.90e-0361922412EFO_0003923, EFO_0004531
Diseasealpha peak frequency measurement, alpha wave measurement, electroencephalogram measurement

CDK19 KIRREL1

3.02e-03112242EFO_0004357, EFO_0006870, EFO_0006883
DiseaseN-acetylphenylalanine measurement

ALMS1 C2orf78

3.02e-03112242EFO_0800019
Diseasealcohol consumption measurement

RELN PDE4B ARHGAP15 FAM114A2 SLC28A3 RBKS CSMD3 INO80D SPTBN5 ALMS1 COBL NR3C2 CACNA1E PCLO DNAH2 LINGO2 GRIP1 COMMD7 LAMTOR3

3.10e-03124222419EFO_0007878
Diseaseverbal-numerical reasoning measurement

ARHGAP15 GATB CACNA1E RBL2 EXOC4

3.31e-031312245EFO_0008394
Diseasesmoking status measurement

DLGAP1 PDE4B GATAD2A ARHGAP15 GATB SLC28A3 RNF13 INO80D ALMS1 NAV2 HERC1 UNC79 FAT3 LINGO2 COMMD7 ROBO2 CEP295 EXOC4

3.41e-03116022418EFO_0006527
DiseaseGlobal developmental delay

KDM3B RNF13 CACNA1E SZT2 ZMIZ1

3.53e-031332245C0557874
Diseasesmoking cessation

CYP2B6 PDE4B CSMD3 ALMS1 CACNA1E RBM33 LINGO2 ROBO2

3.55e-033252248EFO_0004319
Diseasealcoholic liver disease

SWT1 NUP43 LINGO2 ROBO1

3.56e-03822244EFO_0008573
DiseaseOligospermia

PIWIL4 CDC14A

3.60e-03122242C0028960
DiseaseAbnormality of the dentition

ROBO2 UNC13C

3.60e-03122242HP_0000164
Diseasethyroxine measurement

KIRREL3 STARD9 UGT1A8 LAMA4

3.72e-03832244EFO_0005130
Diseasesleep measurement

FAM114A2 SLC28A3 PXDN GKAP1 ROBO2

3.76e-031352245EFO_0004870
DiseaseCharcot-Marie-Tooth disease

DNAJB2 JPH1 IGHMBP2

3.98e-03422243cv:C0007959
Diseasetestosterone measurement

KIF18A DLGAP1 PDE4B SLC28A3 CSMD3 NEDD9 KCNQ5 PHIP ARHGEF6 RNF19A UGT1A8 DNAH2 LINGO2 EBF1 ZMIZ1 UBE3D SLCO1A2 GKAP1 MYO16

4.10e-03127522419EFO_0004908
Diseasefructose measurement

UBR4 P2RY1

4.24e-03132242EFO_0010477
Diseasebipolar I disorder

KDM3B STARD9 CACNB2 CUBN MYO16

4.52e-031412245EFO_0009963
Diseasebronchopulmonary dysplasia

CSMD3 ZNF770 HIVEP3

4.84e-03452243MONDO_0019091
Diseasealkaline phosphatase measurement

CYP2B6 ARHGAP15 GATB KIRREL3 POM121 NR3C2 CLEC10A HOMEZ FAM210A RBL2 EBF1 ZMIZ1 ZFAND4 HIVEP3 AKAP13 UNC13C

4.89e-03101522416EFO_0004533
Diseaseglucose-dependent insulinotropic peptide measurement, glucose tolerance test

ARHGEF17 CLEC10A

4.92e-03142242EFO_0004307, EFO_0008464
Diseasepulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio

THSD4 MUC21 ARHGEF17

5.47e-03472243EFO_0003892, EFO_0004713, EFO_0005671
Diseasediffuse plaque measurement

RELN PDE4B ARHGAP15 GATB CSMD3 KCNQ5 ADAMTS18 SLAIN1 CACNB2 RBBP5 EBF1 ROBO2 MYO16

5.51e-0375822413EFO_0010699
Diseasemyeloid cell surface antigen CD33 measurement

VSIG10L SIGLEC12

5.64e-03152242EFO_0008238
DiseaseProteinuria

CUBN UNC13C

5.64e-03152242HP_0000093
Diseaseintraocular pressure measurement

RELN COL24A1 ADAMTS18 KMT2A HERC2 ARHGAP20 LRP12 PCLO HIVEP3 AKAP13

5.79e-0350922410EFO_0004695
Diseaseage at menarche

DLGAP1 KDM3B SLC28A3 KIRREL3 ALMS1 GABPB2 UNC79 DNAH2 FAM83B UNC13C GABPB1

5.99e-0359422411EFO_0004703
DiseaseCardiovascular Abnormalities

ZMIZ1 ZNF292

6.42e-03162242C0243050
DiseaseRolandic epilepsy

PTCHD3 NR3C2

6.42e-03162242Orphanet_1945
Diseaseunipolar depression, bipolar disorder

ARHGAP15 GSDME STARD9 CACNA1E PCLO

6.90e-031562245EFO_0003761, MONDO_0004985
Diseasewellbeing measurement

KIRREL3 GSDME KMT2A NR3C2 HERC1 CACNA1E PCLO LINGO2 FAM83B NCOA5 UBE3D ELP4

6.93e-0369222412EFO_0007869
Diseaseuridine diphosphate galactose measurement, uridine diphosphate glucose measurement

SVIL ADAMTS18

7.24e-03172242EFO_0010543, EFO_0010544
Diseaseresponse to homoharringtonine, cytotoxicity measurement

METTL3 RNF6

7.24e-03172242EFO_0006952, EFO_0006996
Diseaseblood cobalt measurement

IGLV10-54 MUC16 CDC14A ROBO2

7.44e-031012244EFO_0007577
Diseasesevere acute respiratory syndrome, COVID-19

THSD4 DLGAP1 RELN COL24A1 KIRREL3 ANOS1 PXDN GRIP1 UNC13C

7.45e-034472249EFO_0000694, MONDO_0100096

Protein segments in the cluster

PeptideGeneStartEntry
GSTSSIIQQYSGTRV

C2orf16

981

Q68DN1
SRNSAQGSFLVSVAE

MAMDC4

306

Q6UXC1
SFRRVFSSSATAQGT

FAM210A

91

Q96ND0
SISTTQVFSLAGSTF

MLLT6

606

P55198
NTLSLFFAGTETTST

CYP2B6

291

P20813
QGAVSSTVSGLQRQS

ARHGEF6

136

Q15052
SSSRLNYQSSVQGSS

CDK19

461

Q9BWU1
TTTTASLAFTAAATQ

CD300LD

136

Q6UXZ3
LTVTSFNASTGRVNA

CSMD3

3516

Q7Z407
FNASTGRVNATLSNS

CSMD3

3521

Q7Z407
NAAFLTGSISNFSRA

C2orf78

56

A6NCI8
NRLSFSSTGSTRSNM

NEDD9

366

Q14511
SSDTTSNSFVRQGSA

CACNB1

46

Q02641
TFEAAVATSLGRSNT

CACNA1E

2251

Q15878
QATFGTFESILRSSQ

CKAP4

166

Q07065
FANFSIVSGTTSITN

ADGRG4

736

Q8IZF6
INRTSLSSGATVRSF

CDC14A

461

Q9UNH5
LSSGATVRSFSINSR

CDC14A

466

Q9UNH5
STGEVLTQNSGFRLS

CD300E

156

Q496F6
LNLGGSSRVESQSSF

GSDME

101

O60443
NATAVTTVRTNASGL

GPR20

16

Q99678
SQAPASTSASTRLFG

AKAP13

2761

Q12802
SSSSVQQVTFSRGTD

ALMS1

3246

Q8TCU4
FTSSSGQQTAQRAEL

C3

646

P01024
QRGDIISQSGLSNST

DLGAP1

576

O14490
SSNSKLFSGSQVRFS

GATB

76

O75879
TTASRFALLQVDSGS

GKAP1

11

Q5VSY0
AQAATSLLASSASQF

ADARB2-AS1

26

A8MUL3
FSTVQSSTAGNTLRN

AMBRA1

371

Q9C0C7
GRLSNTQGVVSAFST

ATP5PO

116

P48047
QGFIRNDSSSSVAVS

ADAMTS18

146

Q8TE60
SDTTSNSFVRQGSAD

CACNB2

61

Q08289
ASQNTTFLTSGSILR

ADNP2

586

Q6IQ32
GRSSTFLSHSISNQA

NUP43

306

Q8NFH3
ARGVGLNSTTQSVLS

RC3H1

116

Q5TC82
NFSSQGVTISLNATS

RBM33

81

Q96EV2
GDIRSAINSLQFSSS

RAD17

331

O75943
RGASQFLASASSSTT

IRX6

11

P78412
AAAFSSQRSGLFTNT

NUP107

111

P57740
NVTFKVTQATSSASA

INPP4A

741

Q96PE3
SSRSAVTASAGLAFQ

MPEG1

231

Q2M385
RNTTSEATFTLLGFS

OR5D16

6

Q8NGK9
TSTAFGNSNNILIAT

NPAT

856

Q14207
SIGNTDSRFFTNLTT

PM20D1

431

Q6GTS8
SAQALAGSLSSQQVT

RBL2

781

Q08999
FIAAVSVQAAGTQSS

RBKS

296

Q9H477
DSFNVVSTRGSLRTQ

CAPN15

1006

O75808
LQSQASRSTISSSFG

ARHGEF17

1651

Q96PE2
LQNSASATALVSRTG

GATAD2A

551

Q86YP4
VTQNSTAEPSRFSSS

FCHO1

331

O14526
LRLANSTVNSDGSVT

ANOS1

296

P23352
SSRTSISGFAQLTVS

MUC16

8161

Q8WXI7
ASSQGTFTLDTSSRA

MUC16

8796

Q8WXI7
GSETSAFSNLTVASS

MUC16

11216

Q8WXI7
SLFVNGFTHRSSVST

MUC16

13746

Q8WXI7
SSFLLQGRTAQTGSA

MUC4

4716

Q99102
GNSTVASTAAVSSSF

P2RY1

26

P47900
SQSGATFFSISASSL

FIGNL1

456

Q6PIW4
TQTGSRSSRASHFQS

FLG2

2316

Q5D862
FILVGFQQSSTSTRA

OR10AD1

11

Q8NGE0
LSRQTSVLNAGNSVF

HDX

176

Q7Z353
FQLTVTDTAGQRSSD

LRP11

276

Q86VZ4
RFTLGRSSSLSQNQS

LRP12

741

Q9Y561
GTISLSRSARDQSFQ

NR3C2

531

P08235
VDQGTSSTRFLVFNS

GK3P

16

Q14409
LANTGVDTTSNSFSI

MGAM2

2186

Q2M2H8
TNSEFSTVSSGISIA

MUC21

91

Q5SSG8
SRLSISGTGTSTFQR

MYO16

1761

Q9Y6X6
VSSSVNQASRLIDGS

HERC2

2791

O95714
STSNSSLTADVNSGF

KIF18A

836

Q8NI77
TSSSVSVISISAANF

KIAA2026

1411

Q5HYC2
GSQARTSFSSVTVSR

KRT79

26

Q5XKE5
LSRSTSANISRGLQF

KCNQ5

676

Q9NR82
ITVNGAVLSSSGTRF

LGALS9B

31

Q3B8N2
ITVNGTVLSSSGTRF

LGALS9

31

O00182
TVLSSSGTRFAVNFQ

LGALS9

36

O00182
VSAVQFGNSSTSVLA

GABPB1

211

Q06547
SISLAGSRLSSGFQS

HERC1

1656

Q15751
GSRLSSGFQSSTLLT

HERC1

1661

Q15751
SGFQSSTLLTSVRLQ

HERC1

1666

Q15751
FLNVFVNSTSRSSST

MAPK8IP2

576

Q13387
SRISSSDANSTISFG

JPH1

246

Q9HDC5
QTASIATASASAQAR

DYNC2I2

66

Q96EX3
AFSTTAINFSTVNSS

CCDC88A

1531

Q3V6T2
AINFSTVNSSAGFRS

CCDC88A

1536

Q3V6T2
SSLASVSSQRNLFGR

FAM83B

311

Q5T0W9
QNFNSSARVSLSGSS

ENTPD2

291

Q9Y5L3
ASIFSQASNLISTAG

PCLO

936

Q9Y6V0
ESFTRGSTSTNAILT

MUC3A

2661

Q02505
HSSSLNNTSISRFGV

PDE4B

316

Q07343
LSLFNSGTVTANSSS

NCOA5

436

Q9HCD5
SSSIRQRISSFETFG

IL16

836

Q14005
QASGENSRNSILASS

KDM3B

456

Q7LBC6
AGTTRFFTSNTHSSV

KLHL9

21

Q9P2J3
SNAAGNDTFTASLTV

LINGO2

486

Q7L985
FETSSTRTDTQSGNL

GDPD4

501

Q6W3E5
SRFQRLSSTSSSGQQ

TMEM63A

91

O94886
FQQSAFNRVVSSVSS

KDM5A

1316

P29375
TVAAFASSLVSGLNS

METTL3

186

Q86U44
VASFRVTTGTSNTTA

RBBP5

186

Q15291
NSLFTVASASGAAST

POU2F1

721

P14859
LNTTTASVLQFSIGS

RELN

256

P78509
NAITSSYSSTRGISQ

POM121

411

Q96HA1
SAIQTSAGATANRFQ

KCTD18

301

Q6PI47
IRFTSDSSVTRAGFN

CUBN

2071

O60494
TSSNTAVVRFVTDGS

CUBN

2421

O60494
ASRTKSAFSNLSTSQ

EXOC4

721

Q96A65
LANQTVVSESSQGSR

IGSF10

1781

Q6WRI0
SFVTSESGFLNSLSS

IPCEF1

261

Q8WWN9
TNAFGARRNTIDSTS

CABLES1

406

Q8TDN4
AGAFRSVSTSTTFVQ

DNAJB2

161

P25686
RVAVFFSNGQTASRS

COL6A5

1866

A8TX70
FSNGQTASRSSIITA

COL6A5

1871

A8TX70
TGTIFTFRSARLNSQ

SERPINA5

366

P05154
RTASRFSTGTLSNTA

COBL

1221

O75128
FSTGTLSNTADARQA

COBL

1226

O75128
SLNVSVSDGLFTSTA

FAT3

2466

Q8TDW7
EFATTNQISLGSLRS

COMMD7

56

Q86VX2
VDQGTSSTRFLVFNS

GK

16

P32189
SAGRQSSLVLQNTSF

ANGPT4

416

Q9Y264
SQATNQGFTRNSSSV

EBF1

451

Q9UH73
AFGVFSTISTAVQST

FAM114A2

151

Q9NRY5
RFSASRSGNTASLTI

IGLV10-54

81

A0A075B6I4
SFIASSSANTGLIVS

LAMTOR3

91

Q9UHA4
TLGQFTRSVLGSSTV

DNAI4

171

Q5VTH9
FTVTGATATSTNNAS

INO80D

1006

Q53TQ3
ITVSRNGSSVFTTSQ

NSMAF

636

Q92636
LSDTFSQGTQTRFSQ

KIRREL1

11

Q96J84
NASVIFSLSQGRSVQ

KHK

261

P50053
VTNALGSTNLSRTVD

KIRREL3

316

Q8IZU9
GNTYSRNNVSSVSTT

KMT2A

2216

Q03164
LFSRFGRSSTTQSSE

DDHD1

761

Q8NEL9
SSTSSSFQVLANGAT

HOMEZ

286

Q8IX15
AFSTSQNGSLSQSSV

CRYBG1

861

Q9Y4K1
SAVATASKSNVTSFQ

ELP4

16

Q96EB1
SQLGRQASFQERSSS

GRIP1

946

Q9Y3R0
TTGRSSRQSSFIAVG

CD163

1041

Q86VB7
VQLSFTSLASAESGT

CEP295

1296

Q9C0D2
TGFLTAVLQSSARQN

DNAH2

4286

Q9P225
RSSFSEGQTLTVTSG

RUBCN

386

Q92622
GSFRVTSSSSQFSSR

RUBCN

561

Q92622
FSVSSFSQITSGLSV

SEC24C

1006

P53992
AASSVRSNLTSFGAD

SLC15A3

171

Q8IY34
ATLGASSQRISQNSE

SCARA3

281

Q6AZY7
VALGAAASTSQTSVQ

SLC39A9

161

Q9NUM3
TAGSSSTRFIANSQE

MENT

131

Q9BUN1
DSATAFGAQTSSRLS

CTU2

401

Q2VPK5
SFSQITRSLFLSNGV

DUSP21

21

Q9H596
SSARSVSQSRLGLSF

PYDC5

91

W6CW81
INISSSNEIISSRGF

PTCHD3

736

Q3KNS1
SSRGFIQTTDVSSSA

PTCHD3

746

Q3KNS1
LQLNGASITSASQTF

LAMA4

1621

Q16363
SFRSLSSAINASTGN

SERPINB2

106

P05120
SQGSVLAFTRTFIAT

NXF2

511

Q9GZY0
TGSQSLGVAISTRSF

MROH5

1116

Q6ZUA9
QFSNSTTSVLATLAA

GABPB2

216

Q8TAK5
SGSSVSSQDSAFSQI

ARHGAP20

946

Q9P2F6
AFASSLSGSLATQAV

RUSF1

101

Q96GQ5
STQATGDSAFTSLSV

SZT2

1091

Q5T011
DLLQRTGNFISTSTS

UTP18

216

Q9Y5J1
TAAVVSRQGSSLNLF

RAB11FIP1

491

Q6WKZ4
RFSTSQVLCSQALSS

RNF135

296

Q8IUD6
RSFAGVAVLSTLQSS

SLC35D3

76

Q5M8T2
QVSGASFSSLRQSVA

TAPBPL

346

Q9BX59
SSSLQQAASRSPSFG

SVIL

251

O95425
TLFISTNSGASAASR

TAB2

406

Q9NYJ8
TVTRLTFSSAYQGNS

TMEM151B

86

Q8IW70
TFIDSSGQFVSSQVT

NXPE3

41

Q969Y0
SGQFVSSQVTGISRN

NXPE3

46

Q969Y0
TNTSLSTSRDASVFQ

TAF1L

1671

Q8IZX4
ANSASVNAISLTSGI

NEXMIF

91

Q5QGS0
VSLRSSSGVLFNQRS

OVCH1

346

Q7RTY7
GSSQFAAVAASSAVR

GNAS

251

Q5JWF2
GSSSVFSVLSNSAEV

PLAAT4

46

Q9UL19
GKSFSTVTNTFRTNN

PIK3R6

661

Q5UE93
SGTRFNFSQLASPTT

NAV2

1561

Q8IVL1
SSSNGFLGTSRISTN

PIWIL4

41

Q7Z3Z4
SSRKNVFQITTVSGN

ARHGAP15

151

Q53QZ3
ASVSAQSFGALSESR

RNF13

316

O43567
RTRSQTSVNFNGSSS

RNF6

196

Q9Y252
SSPVTVRNSQSFDSS

SLAIN1

421

Q8ND83
RRNTTTGASAAAVAS

SIPA1L1

356

O43166
SASQLFVRLSSTGQR

SHKBP1

516

Q8TBC3
TGLSTSAIATNGFVR

SLC12A1

226

Q13621
QDGLSTAVQTFSNRS

SLC41A2

66

Q96JW4
ESTVSVSGNLSSNSF

SLCO1A2

116

P46721
TGTSAQQLDSSFSTN

SEC31B

26

Q9NQW1
FAGSTALSRSAVQES

SLC26A3

391

P40879
ATQGASSSISLVANI

SLC28A3

436

Q9HAS3
SLSASRSTNAQVFAT

STARD9

1596

Q9P2P6
TDVFQRLGSNSALTT

SWT1

771

Q5T5J6
RSGTSNSQSQAKTYT

PLK4

381

O00444
SFQTGLFTAARQSTN

PROS1

91

P07225
TVFQGDGTASTTLRN

SIGLEC12

371

Q96PQ1
ASARASLFTVNSALS

SPTBN5

811

Q9NRC6
SFIQNLVSASLGSTS

BIRC2

111

Q13490
QRFLSTQVGSAIISS

ADGRD2

561

Q7Z7M1
LNSTTSSSTTFGAFR

C21orf62-AS1

16

Q17RA5
TLRTDFSNFTSNTVA

CLEC10A

71

Q8IUN9
DGSTFSSNLFQIRTT

CLEC7A

196

Q9BXN2
STIAVRDSASNGSIF

CLRN3

36

Q8NCR9
VALVSFSSGFSQSIT

CLCNKA

101

P51800
VALVSFSSGFSQSIT

CLCNKB

101

P51801
SSNSGFDSSVASQIT

CNOT11

251

Q9UKZ1
RSQLSSLQSGNVSAV

COL24A1

311

Q17RW2
ATFQTTQGFIVTASR

PIK3R4

1336

Q99570
STSGDVVSRNQSFLR

SAV1

61

Q9H4B6
GFTSTATADSRALLQ

TXNRD1

46

Q16881
QAAIASQRFEGTTSL

VPS26B

306

Q4G0F5
SSGTVQLTTTSRAEF

PHF6

246

Q8IWS0
GRFRTLSQSTANESS

UNC13C

831

Q8NB66
IQFSNTSNRFVSGSR

PHIP

371

Q8WWQ0
NSIFSTNTSSDNGLT

RNF19A

106

Q9NV58
SSSVANFLQARGLAS

SLC27A4

111

Q6P1M0
TLSSSGAVSAFQRRV

SH3RF3

356

Q8TEJ3
SLTSANVVLATNTGA

IGHMBP2

341

P38935
LSSARSTFRFTIQGQ

UBE3D

261

Q7Z6J8
STVVALSQARFSDGQ

PXDN

831

Q92626
SQNFTSNSSRVSVIS

ZNF292

1596

O60281
SNVSLSGSSRSASFE

HIVEP3

936

Q5T1R4
QSVTVLTVGSYNSTS

ROBO2

741

Q9HCK4
ATVNLTVSSSSYGSQ

USF3

1271

Q68DE3
SSSRFSVSQTGDLTI

ROBO1

401

Q9Y6N7
SSVASVAAGTSFQVL

PIGZ

6

Q86VD9
QSSEQTQRTFVGSLG

ZNF770

376

Q6IQ21
TQANTFASRVSSLAE

WASF2

56

Q9Y6W5
QSATVLGTQIFTSGR

TRIML1

326

Q8N9V2
SVCNASFTTNGSLTR

ZNF236

1026

Q9UL36
ATRLFEANQTIATSG

TSPEAR

461

Q8WU66
TLRASSGLQQTNFSS

VSIG10L

21

Q86VR7
ATQSFSQPARSTAIS

THSD4

276

Q6ZMP0
NISFLASLAGSTSRN

ZFAND4

566

Q86XD8
TGTFALTSLISANAV

SLC26A7

101

Q8TE54
AFSGTLSTVASSINA

SLC5A12

341

Q1EHB4
TNRNQRSSSFGSVST

SNX16

21

P57768
LRASVVTASSGSALQ

UBR4

3251

Q5T4S7
GQTSRLSASSTFQSI

TTLL4

1176

Q14679
LFTLQTVNSNGTSDR

USP11

716

P51784
GSSSTSRNQVASLAY

nan

146

Q96M66
TSGFVSSNQRNTTAT

SAMD4A

616

Q9UPU9
NDVLAFGTLVSTSNT

TPK1

206

Q9H3S4
RNFSSVAASSGNTTL

ZMIZ1

711

Q9ULJ6
TTRNNTSFNISEGIL

TAS2R4

161

Q9NYW5
QVRSLFSLFLSSSNG

UGT1A8

101

Q9HAW9
ARTLQGIGSSFSSVA

SLC18A1

196

P54219
SVGRLASSTTFSNQA

UNC79

2051

Q9P2D8
LSASQDGTLQSFSTV

WDR36

396

Q8NI36
RVSQSFGLQTTSADR

VPS13D

581

Q5THJ4
SQTQASETLAVRGFS

MYSM1

636

Q5VVJ2